Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences exploring how ribonucleic acid, known as RNA, can be harnessed to develop ...

Arcturus Therapeutics (ARCT) stock falls as Citi downgrades the company following weak mid-stage trial data for its cystic ...

Experiments on yeast show that the nuclear pore complex has a central role in the loss of chromosomes associated with aging.

Shares of Arcturus Therapeutics Holdings fell sharply premarket amid fears about patient complications in the wake of a mid-stage trial of a biotech spray treatment for cystic fibrosis that had mixed ...

New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development. It ...

High-fidelity visualization of a fetal heart is essential for deep understanding about heart myofibers orientation and the ...

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease.

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

A team of scientists has mapped the regions surrounding stem cells in planarians—small flatworms that are famous for being able to regrow whole bodies from small fragments—and discovered something ...